EDITORIAL
Published on 03 May 2021
Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
doi 10.3389/fimmu.2021.691899
- 1,632 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
38k
Total downloads
122k
Total views and downloads
Articles
MINI REVIEW
Published on 27 Jan 2021
Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion via Mechanisms Similar and Distinct From CTLA-4 and PD-1
doi 10.3389/fimmu.2020.531910
- 3,974 views
- 17 citations
ORIGINAL RESEARCH
Published on 06 Oct 2020
The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation
doi 10.3389/fimmu.2020.02128
- 4,372 views
- 10 citations
REVIEW
Published on 16 Sep 2020
Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy
doi 10.3389/fimmu.2020.02186
- 6,200 views
- 41 citations
ORIGINAL RESEARCH
Published on 03 Sep 2020
Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer
doi 10.3389/fimmu.2020.01678
- 11,949 views
- 73 citations
REVIEW
Published on 14 Aug 2020
Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings
doi 10.3389/fimmu.2020.01958
- 4,459 views
- 19 citations
MINI REVIEW
Published on 28 Jul 2020
Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies
doi 10.3389/fimmu.2020.01633
- 6,885 views
- 36 citations
REVIEW
Published on 07 Jul 2020
Clinical and Recent Patents Applications of PD-1/PD-L1 Targeting Immunotherapy in Cancer Treatment—Current Progress, Strategy, and Future Perspective
doi 10.3389/fimmu.2020.01508
- 15,594 views
- 71 citations
CASE REPORT
Published on 07 Jul 2020
Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report
doi 10.3389/fonc.2020.01073
- 2,558 views
- 14 citations
CASE REPORT
Published on 19 Jun 2020
Durable Response and Good Tolerance to the Triple Combination of Toripalimab, Gemcitabine, and Nab-Paclitaxel in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma
doi 10.3389/fimmu.2020.01127
- 3,480 views
- 11 citations
REVIEW
Published on 29 May 2020
Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
doi 10.3389/fimmu.2020.01075
- 9,425 views
- 50 citations
REVIEW
Published on 15 May 2020
TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy
doi 10.3389/fimmu.2020.00922
- 14,805 views
- 69 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore